• LAST PRICE
    3.8750
  • TODAY'S CHANGE (%)
    Trending Down-0.0550 (-1.3995%)
  • Bid / Lots
    3.8700/ 13
  • Ask / Lots
    3.8800/ 5
  • Open / Previous Close
    3.9300 / 3.9300
  • Day Range
    Low 3.8450
    High 3.9600
  • 52 Week Range
    Low 3.7200
    High 8.4500
  • Volume
    159,274
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.93
TimeVolumeOSUR
09:32 ET40513.94
09:33 ET44503.92
09:35 ET42373.91
09:37 ET41113.9
09:39 ET1003.91
09:44 ET149873.91
09:50 ET40103.89
09:51 ET8333.89
09:53 ET6003.895
10:02 ET12003.89
10:04 ET48943.87
10:06 ET3003.875
10:08 ET66003.88
10:09 ET37163.88
10:11 ET2003.88
10:13 ET18923.875
10:15 ET128613.895
10:18 ET6003.88
10:20 ET63073.89
10:22 ET1003.895
10:24 ET11833.875
10:26 ET2103.8752
10:29 ET3003.875
10:31 ET4003.87
10:33 ET84043.88
10:36 ET2003.875
10:38 ET130143.875
10:40 ET1003.875
10:44 ET153273.86
10:45 ET72903.855
10:47 ET34773.865
10:51 ET1003.86
10:54 ET4003.865
10:56 ET15003.87
10:58 ET51823.88
11:00 ET62003.8808
11:02 ET61003.875
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOSUR
OraSure Technologies Inc
289.4M
25.7x
+75.98%
United StatesANGO
AngioDynamics Inc
277.5M
-1.2x
---
United StatesNVRO
Nevro Corp
169.4M
-2.3x
---
United StatesZIMV
ZimVie Inc
391.1M
-8.2x
---
United StatesINGN
Inogen Inc
223.4M
-4.3x
---
United StatesCERS
Cerus Corp
332.4M
-16.3x
---
As of 2024-11-26

Company Information

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Contact Information

Headquarters
220 E First StBETHLEHEM, PA, United States 18015
Phone
503-641-6115
Fax
610-882-1830

Executives

Independent Chairman of the Board
Mara Aspinall
President, Chief Executive Officer, Director
Carrie Eglinton Manner
Chief Financial Officer
Kenneth Mcgrath
Chief Product Officer
Kathleen Weber
Independent Director
James Datin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$289.4M
Revenue (TTM)
$224.3M
Shares Outstanding
74.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.04
EPS
$0.15
Book Value
$5.86
P/E Ratio
25.7x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
11.8x
Operating Margin
-5.32%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.